Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia
- 1 April 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 57 (11) , 941-946
- https://doi.org/10.1016/0002-9149(86)90735-6
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: A randomized crossover studyAmerican Heart Journal, 1985
- Cibenzoline for treatment of ventricular arrhythmias: A double-blind placebo-controlled studyJournal of the American College of Cardiology, 1984
- Single-Dose Pharmacokinetics and Dose Proportionality of Oral CibenzolineThe Journal of Clinical Pharmacology, 1984
- Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmiasJournal of the American College of Cardiology, 1984
- Clinical and electrophysiologic effects of chronic lorcainide therapy in refractory ventricular tachycardiaJournal of the American College of Cardiology, 1983
- Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugsBritish Journal of Pharmacology, 1983
- Chronic effects of amiodarone in patients with refractory ventricular tachycardiaInternational Journal of Cardiology, 1983
- Chronic electrophysiologic testing in patients with recurrent sustained ventricular tachycardiaThe American Journal of Cardiology, 1979
- Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.Circulation, 1978
- The effect of amiodarone, a new anti‐anginal drug, on cardiac muscleBritish Journal of Pharmacology, 1970